• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
79,273.33 753.03
( 0.96%)
Global Indices
Nasdaq
49,464.98 -3.46
(-0.01%)
Dow Jones
7,130.75 -16.31
(-0.23%)
Hang Seng
59,361.39 536.50
(0.91%)
Nikkei 225
10,604.22 -63.41
(-0.59%)
Forex
USD-INR
92.58 -0.61
(-0.65%)
EUR-INR
108.87 -0.98
(-0.89%)
GBP-INR
125.07 -1.17
(-0.93%)
JPY-INR
0.58 0.00
(-0.45%)

EQUITY - MARKET SCREENER

Persistent Systems Ltd
Industry :  Computers - Software - Large
BSE Code
ISIN Demat
Book Value()
533179
INE262H01021
419.7939778
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PERSISTENT
53.38
83957.71
EPS(TTM)
Face Value()
Div & Yield %
99.7
5
0.65
 

kaizen agro infrbuild ltd
Natco Pharma receives USFDA EIR report for API unit in Chennai
Feb 13,2026
NATCO Pharma announced that the U.S. Food and Drug Administration (FDA) had conducted an inspection at the Active Pharmaceutical Ingredient Division located in Manali, Chennai from 17 November – 21 November 2025. The Company received seven (7) observation in the Form-483.

Further, the Company has received the EIR (Establishment Inspection Report) from the USFDA on the classification of the above-referred inspection as Voluntary Action Indicated (VAI).